MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$9,947K
Free Cash flow
$3,861K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from exercise of stock ...
Share-based compensation
Net income (loss)
Others
Negative Cash Flow Breakdown
Proceeds from initial public off...
Accounts receivable
Deferred revenue
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Net income (loss)
5,294
14,967
-3,178
-14,759
Depreciation and amortization
1,581
-2,536
1,359
2,685
Share-based compensation
5,631
-5,001
3,536
5,674
Loss on debt extinguishment
-
-
-2,109
-
Loss on disposal of property and equipment
-25
0
0
-2
Amortization of debt issuance costs
0
-285
33
252
Non-cash operating lease expense
0
-447
65
382
Change in fair value of warrant liabilities
0
-1,468
212
1,256
Provision for credit losses
383
-679
995
490
Amortization of deferred commissions
968
-1,509
906
1,561
Accounts receivable
16,971
-13,308
9,154
10,360
Inventory
288
-507
-321
173
Prepaid expenses and other current assets
-1,279
-31
700
870
Deferred commissions
655
-117
896
1,423
Other non-current assets
-11
242
-63
-118
Accounts payable
3,650
-3,497
357
1,016
Operating lease liabilities
0
415
0
-415
Accrued expenses and other current liabilities
4,751
-16,947
12,562
-4,780
Deferred revenue
-1,652
-3,332
1,632
5,995
Other non-current liabilities
0
0
-89
89
Net cash used in operating activities
4,007
-8,707
10,133
-13,260
Purchases of property and equipment
146
-1,045
537
586
Capitalized internal-use software costs
1,518
-1,884
1,450
1,913
Net cash used in investing activities
-1,664
2,929
-1,987
-2,499
Proceeds from exercise of stock options
8,137
-2,746
2,085
3,908
Taxes paid related to net share settlement of equity awards
533
127
-
-
Payment of deferred offering costs
0
-4,284
2,357
1,927
Repayment of debt principal
-
-
30,963
-
Payment of debt extinguishment costs
-
-
1,430
-
Proceeds from initial public offering, net of underwriting discounts and commissions
-160,532
-
0
160,532
Net cash provided by financing activities
7,604
-126,728
-32,665
162,513
Net increase (decrease) in cash and cash equivalents
9,947
-132,506
-24,519
146,754
Cash and cash equivalents at beginning of period
198,627
198,627
76,392
-
Cash and cash equivalents at end of period
221,712
211,765
198,627
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
something is missing
$160,532K
Share-based compensation
$5,631K
(-0.76%↓ Y/Y)
Proceeds from exercise of
stock options
$8,137K
(108.21%↑ Y/Y)
Net income (loss)
$5,294K
(135.87%↑ Y/Y)
Accrued expenses and
other current...
$4,751K
(199.39%↑ Y/Y)
Accounts payable
$3,650K
(259.25%↑ Y/Y)
Depreciation and
amortization
$1,581K
(-41.12%↓ Y/Y)
Prepaid expenses and
other current assets
-$1,279K
(-247.01%↓ Y/Y)
Amortization of deferred
commissions
$968K
(-37.99%↓ Y/Y)
Provision for credit
losses
$383K
(-21.84%↓ Y/Y)
Loss on disposal of
property and equipment
-$25K
(-1150.00%↓ Y/Y)
Other non-current
assets
-$11K
(90.68%↑ Y/Y)
Net cash provided by
financing activities
$7,604K
(-95.32%↓ Y/Y)
Net cash used in
operating activities
$4,007K
(130.22%↑ Y/Y)
Canceled cashflow
$161,065K
Canceled cashflow
$19,566K
Net increase
(decrease) in cash and cash...
$9,947K
(-93.22%↓ Y/Y)
Canceled cashflow
$1,664K
Proceeds from initial
public offering, net of...
-$160,532K
(-200.00%↓ Y/Y)
Taxes paid related to
net share...
$533K
Accounts receivable
$16,971K
(63.81%↑ Y/Y)
Deferred revenue
-$1,652K
(-127.56%↓ Y/Y)
Deferred commissions
$655K
(-53.97%↓ Y/Y)
Inventory
$288K
(66.47%↑ Y/Y)
Net cash used in
investing activities
-$1,664K
(33.41%↑ Y/Y)
Capitalized internal-use
software costs
$1,518K
(-20.65%↓ Y/Y)
Purchases of property and
equipment
$146K
(-75.09%↓ Y/Y)
Buy us a coffee
Omada Health, Inc. (OMDA)
Omada Health, Inc. (OMDA)